Qyuns Therapeutics Co Ltd (2509.HK)

HKD 11.24

(1.81%)

Total Liabilities Summary of Qyuns Therapeutics Co Ltd

  • Qyuns Therapeutics Co Ltd's latest annual total liabilities in 2023 was 544.59 Million CNY , up 29.8% from previous year.
  • Qyuns Therapeutics Co Ltd's latest quarterly total liabilities in 2024 Q1 was 711.94 Million CNY , up 30.73% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported annual total liabilities of 419.55 Million CNY in 2022, down -5.6% from previous year.
  • Qyuns Therapeutics Co Ltd reported annual total liabilities of 444.44 Million CNY in 2021, down 0.0% from previous year.
  • Qyuns Therapeutics Co Ltd reported quarterly total liabilities of 711.94 Million CNY for 2024 Q1, up 30.73% from previous quarter.
  • Qyuns Therapeutics Co Ltd reported quarterly total liabilities of 544.59 Million CNY for 2023 Q4, up 24.82% from previous quarter.

Annual Total Liabilities Chart of Qyuns Therapeutics Co Ltd (2023 - 2021)

Historical Annual Total Liabilities of Qyuns Therapeutics Co Ltd (2023 - 2021)

Year Total Liabilities Total Liabilities Growth
2023 544.59 Million CNY 29.8%
2022 419.55 Million CNY -5.6%
2021 444.44 Million CNY 0.0%

Peer Total Liabilities Comparison of Qyuns Therapeutics Co Ltd

Name Total Liabilities Total Liabilities Difference
Uni-Bio Science Group Limited 152.81 Million HKD -256.367%
CK Life Sciences Int'l., (Holdings) Inc. 7.05 Billion HKD 92.284%